A Clinical Comparison of Three Contact Lens Care Systems and Their Effect on Contact Lenses
Not Applicable
Completed
- Conditions
- Contact Lenses
- Interventions
- Device: Opti-Free RepleniSH multi-purpose disinfecting solutionDevice: ReNu MultiPlus multi-purpose solutionDevice: Clear Care cleaning and disinfecting systemDevice: Lotrafilcon B contact lens (AIR OPTIX AQUA)Device: Senofilcon A contact lens (ACUVUE OASYS)Device: Comfilcon A contact lens (Biofinity)
- First Posted Date
- 2009-09-22
- Last Posted Date
- 2016-11-16
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 75
- Registration Number
- NCT00982046
- Locations
- 🇬🇧
Visioncare Research Ltd., Farnham, Surrey, United Kingdom
Safety and Efficacy of Olopatadine 0.6% and Azelastine 137 Mcg in Vasomotor Rhinitis
Phase 4
Completed
- Conditions
- Vasomotor Rhinitis
- Interventions
- Drug: Olopatadine HCL (Patanase) Nasal Spray, 0.6%Drug: Azelastine HCl (Astelin) Nasal Spray, 137 mcg
- First Posted Date
- 2009-09-18
- Last Posted Date
- 2011-05-10
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 129
- Registration Number
- NCT00979615
- Locations
- 🇺🇸
Contact Alcon Call Center For Trial Locations, Fort Worth, Texas, United States
Efficacy and Safety of Travoprost 0.004% Versus Tafluprost 0.0015% in Patients With Primary Open-angle Glaucoma or Ocular Hypertension
Phase 4
Completed
- Conditions
- Glaucoma
- Interventions
- Drug: Travoprost 0.004% ophthalmic solution (TRAVATAN)Drug: Tafluprost 0.0015% ophthalmic solution
- First Posted Date
- 2009-08-27
- Last Posted Date
- 2012-06-20
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 51
- Registration Number
- NCT00966940
ACRYSOF® Toric NATURAL T9 Intraocular Lens (IOL)
Not Applicable
Completed
- Conditions
- Bilateral Cataract
- Interventions
- Device: ACRYSOF® Single-Piece NATURAL Toric IOL Model SN60T9 and Model SN60T8.
- First Posted Date
- 2009-08-27
- Last Posted Date
- 2017-01-09
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 15
- Registration Number
- NCT00967473
- Locations
- 🇺🇸
Alcon Call Center for Trial Locations, Fort Worth, Texas, United States
Efficacy and Safety of Adding Azarga to Prostaglandin Monotherapy
Phase 4
Completed
- Conditions
- Glaucoma
- Interventions
- Drug: Brinzolamide/Timolol Maleate Fixed Combination (AZARGA)
- First Posted Date
- 2009-08-27
- Last Posted Date
- 2016-11-21
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 47
- Registration Number
- NCT00966576
Presbyopia-Correcting Intraocular Lenses (IOLs)
Phase 4
Completed
- Conditions
- Cataract
- Interventions
- Device: ReSTOR +3Device: Crystalens HDDevice: Crystalens AO
- First Posted Date
- 2009-08-21
- Last Posted Date
- 2011-08-09
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 132
- Registration Number
- NCT00963560
- Locations
- 🇺🇸
Contact Alcon Call Center For Trial Locations, Fort Worth, Texas, United States
Safety and Efficacy of Brinzolamide/Brimonidine Fixed Combination
Phase 2
Terminated
- Conditions
- Open-Angle GlaucomaOcular Hypertension
- Interventions
- Drug: Brinzolamide 1%/brimonidine tartrate 0.2% ophthalmic suspensionDrug: Brinzolamide ophthalmic suspension, 1%Drug: Brimonidine tartrate ophthalmic solution, 0.2%Other: Vehicle
- First Posted Date
- 2009-08-19
- Last Posted Date
- 2013-07-04
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 195
- Registration Number
- NCT00961649
Barrier Function Measurement in Dry Eye Patients After Using Systane Ultra for 30 Days
Not Applicable
Completed
- Conditions
- Dry Eye
- Interventions
- Other: Systane® Ultra
- First Posted Date
- 2009-07-27
- Last Posted Date
- 2016-11-18
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 19
- Registration Number
- NCT00946777
Subjective and Conjunctival Response to Edge Design of Different Silicone Hydrogels
Not Applicable
Completed
- Conditions
- Contact Lenses
- Interventions
- Device: Lotrafilcon B contact lens (Air Optix)Device: Balafilcon A contact lens (PureVision)Device: Senofilcon A contact lens (Acuvue Oasys)Device: Etafilcon A contact lens (Acuvue 2)Device: Comfilcon A contact lens (Biofinity)Device: Contact lens care system (EasySept)
- First Posted Date
- 2009-07-16
- Last Posted Date
- 2016-11-16
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 30
- Registration Number
- NCT00940459
- Locations
- 🇬🇧
Optometric Technology Group Ltd, London, United Kingdom
Macular Edema Incidence/Severity Reduction With Nevanac
Phase 3
Terminated
- Conditions
- Diabetic Retinopathy
- Interventions
- Drug: Nepafenac ophthalmic suspension, 0.1% (NEVANAC®)Drug: Nepafenac ophthalmic suspension vehicle
- First Posted Date
- 2009-07-14
- Last Posted Date
- 2012-10-23
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 175
- Registration Number
- NCT00939276
- Locations
- 🇺🇸
Contact Alcon Call Center For Trial Locations, Fort Worth, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath